Atlas Venture Life Science Advisors, LLC

Q4 2021 13F Holdings Report, Stock Holdings

Signature - Title
Ommer Chohan - CFO
Location
Cambridge, MA
Holdings as of
31 Dec 2021
Value $
$1,088,761,000
Num holdings
16
Filing time
16 May 2022, 15:53:34 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included KYMR, DAWN, DYN, REPL, and IKNA.
Next filing
Q1 2022 - 16 May 2022
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Ommer Chohan CFO Cambridge, Massachusetts 16 May 2022